Ocugen Shares Outstanding History (OCGN)
Ocugen reported 312.4M shares outstanding at the end of fiscal 2025.
View full Ocugen company overviewOcugen annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 312.4M | 21.0M | +7.21% |
| 2024 | 2024-12-31 | 291.4M | 34.8M | +13.56% |
| 2023 | 2023-12-31 | 256.6M | 35.0M | +15.78% |
| 2022 | 2022-12-31 | 221.6M | 22.2M | +11.14% |
| 2021 | 2021-12-31 | 199.4M | 15.4M | +8.35% |
| 2020 | 2020-12-31 | 184.0M | 131.4M | +249.66% |
| 2019 | 2019-12-31 | 52.6M | 47.7M | +960.87% |
| 2018 | 2018-12-31 | 5.0M | −19.6M | −79.81% |
| 2017 | 2017-12-31 | 24.6M | 3.9M | +19.00% |
| 2016 | 2016-12-31 | 20.6M | 7.4M | +55.56% |
| 2015 | 2015-12-31 | 13.3M | 518,458 | +4.06% |
| 2014 | 2014-12-31 | 12.8M | — | — |
Ocugen quarterly shares outstanding
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 339.0M | 46.9M | +16.03% |
| Q1 2026 | 2026-03-31 | 338.3M | 46.3M | +15.85% |
| Q4 2025 | 2025-12-31 | 312.4M | 21.0M | +7.21% |
| Q3 2025 | 2025-09-30 | 312.3M | 22.1M | +7.60% |
| Q2 2025 | 2025-06-30 | 292.2M | 34.8M | +13.51% |
| Q1 2025 | 2025-03-31 | 292.0M | 34.7M | +13.49% |
| Q4 2024 | 2024-12-31 | 291.4M | 34.8M | +13.56% |
| Q3 2024 | 2024-09-30 | 290.3M | 33.8M | +13.16% |
| Q2 2024 | 2024-06-30 | 257.4M | 934,072 | +0.36% |
| Q1 2024 | 2024-03-31 | 257.3M | 30.9M | +13.65% |
| Q4 2023 | 2023-12-31 | 256.6M | 35.0M | +15.78% |
| Q3 2023 | 2023-09-30 | 256.5M | 39.8M | +18.37% |
| Q2 2023 | 2023-06-30 | 256.5M | 40.3M | +18.66% |
| Q1 2023 | 2023-03-31 | 226.4M | 10.8M | +5.01% |
| Q4 2022 | 2022-12-31 | 221.6M | 22.2M | +11.14% |
| Q3 2022 | 2022-09-30 | 216.7M | 17.8M | +8.93% |
| Q2 2022 | 2022-06-30 | 216.1M | 17.5M | +8.78% |
| Q1 2022 | 2022-03-31 | 215.6M | 27.5M | +14.60% |
| Q4 2021 | 2021-12-31 | 199.4M | 15.4M | +8.35% |
| Q3 2021 | 2021-09-30 | 198.9M | 36.9M | +22.77% |
| Q2 2021 | 2021-06-30 | 198.7M | 63.7M | +47.17% |
| Q1 2021 | 2021-03-31 | 188.2M | 135.5M | +257.54% |
| Q4 2020 | 2020-12-31 | 184.0M | 131.4M | +249.66% |
| Q3 2020 | 2020-09-30 | 162.0M | 152.0M | +1518.06% |
| Q2 2020 | 2020-06-30 | 135.0M | 40.4M | +42.71% |
| Q1 2020 | 2020-03-31 | 52.6M | −42.0M | −44.37% |
| Q4 2019 | 2019-12-31 | 52.6M | −9.4M | −15.16% |
| Q3 2019 | 2019-09-30 | 10.0M | −25.0M | −71.39% |
| Q2 2019 | 2019-06-30 | 94.6M | 65.8M | +228.57% |
| Q1 2019 | 2019-03-31 | 94.6M | 65.9M | +229.76% |
| Q4 2018 | 2018-12-31 | 62.0M | 37.5M | +152.43% |
| Q3 2018 | 2018-09-30 | 35.0M | 12.2M | +53.58% |
| Q2 2018 | 2018-06-30 | 28.8M | 6.5M | +29.24% |
| Q1 2018 | 2018-03-31 | 28.7M | 6.5M | +29.41% |
| Q4 2017 | 2017-12-31 | 24.6M | 3.9M | +19.00% |
| Q3 2017 | 2017-09-30 | 22.8M | 6.9M | +43.59% |
| Q2 2017 | 2017-06-30 | 22.3M | 9.0M | +67.83% |
| Q1 2017 | 2017-03-31 | 22.2M | 8.9M | +67.00% |
| Q4 2016 | 2016-12-31 | 20.6M | 7.4M | +55.56% |
| Q3 2016 | 2016-09-30 | 15.9M | 2.6M | +19.58% |
| Q2 2016 | 2016-06-30 | 13.3M | 37,593 | +0.28% |
| Q1 2016 | 2016-03-31 | 13.3M | 54,395 | +0.41% |
| Q4 2015 | 2015-12-31 | 13.3M | 518,458 | +4.06% |
| Q3 2015 | 2015-09-30 | 13.3M | — | — |
| Q2 2015 | 2015-06-30 | 13.2M | — | — |
| Q1 2015 | 2015-03-31 | 13.2M | — | — |
| Q4 2014 | 2014-12-31 | 12.8M | — | — |
Ocugen shares outstanding trends
Over the last five reported fiscal years, Ocugen's shares outstanding moved from 184.0M to 312.4M, a change of 128.4M. The latest reported quarter, Q2 2026, shows 339.0M.
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Ocugen filings at SEC.gov ↗